Progress report on the Nordic Diltiazem Study (NORDIL): An outcome study in hypertensive patients

Blood Pressure

Volumn 8, Issue 5-6, 1999, Pages 296-299

  Hedner, Thomas ^a  

^a SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Diltiazem; Hypertension; Intervention study; Morbidity; Mortality

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM ANTAGONIST; DILTIAZEM; DIURETIC AGENT;

ADULT; AGED; ANTIHYPERTENSIVE THERAPY; ARTICLE; BLOOD PRESSURE MONITORING; CLINICAL TRIAL; DIABETES MELLITUS; FEMALE; HEART INFARCTION; HUMAN; HYPERTENSION; ISCHEMIC HEART DISEASE; KIDNEY DISEASE; MAJOR CLINICAL STUDY; MALE; MORBIDITY; MORTALITY; MULTICENTER STUDY; NORWAY; PRIORITY JOURNAL; RISK FACTOR; SMOKING; STROKE; SWEDEN; TREATMENT OUTCOME;

EID: 0033494164     PISSN: 08037051     EISSN: None     Source Type: Journal    
DOI: 10.1080/080370599439517     Document Type: Article

References (16)

1. Mancia G, Grassi G. Considerations on current and future trials in hypertension. Blood Pressure 1996; 5: 327-332.
2. Collins R, Peto R, MacMahon S, et al. Blood pressure, stroke and coronary heart disease. Part 2, short-term reductions in blood pressure: over-view of randomized drug trials in their epidemiological context. Lancet 1990; 335: 827-38.
3. Medical Research Working group. MRC trial on treatment of mild hypertension: principal results. Br Med J 1985; 291: 97-104.
4. The Australian Therapeutic Trial on Mild Hypertension Report by the Management Committee Lancet 1980; I: 1261-7.
5. Hypertension Detection and Follow-up Program Cooperative Group. Five-year finding on the Hypertension, Detection and Follow-up Program. Reduction in mortality of persons with high blood pressure including mild hypertension. JAMA 1979; 242: 2562-71.
6. Amery A, Birkenhäger W, Brixhko P, et al. Mortality and morbidity results from the European Working Party on High Blood Pressure in the Elderly trial. Lancet 1985; I: 1349-54.
7. Coope J, Warrender TS. Randomized trial of treatment of hypertension in elderly patients in primary care. Br Med J 1986; 293: 1145-8.
8. Dahlöf B, Lindholm L, Hansson L, Scherstén B, Ekbom T, Wester P-O. Morbidity and mortality in the Swedish Trial in Old Patients with Hypertension (STOP-Hypertension). Lancet 1991; 338: 1281-5.
9. MRC Working Party. Medical Research Council trial of treatment of hypertension in older adults: principal results. Br Med J 1992; 304: 405-12.
10. SHEP Cooperative Research Group. Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension: final results of the Systolic Hypertension in the Elderly Program. JAMA 1991; 265: 3255-64.
11. Staessen J, Fagard R, Thijs L, et al for the SYST-EUR Investigators. Randomized double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertension. Lancet 1997; 350: 757-64.
12. Liu L, Wang JG, Gong L, et al. Comparison of active treatment and placebo for older Chinese patients with isolated systolic hypertension. J Hypertension 1998; 16: 1823-9.
13. Dahlöf B, Hansson L, Lindholm LH, et al. STOP -Hypertension 2 - a prospective intervention trial of "newer" versus "older" treatment alternatives in essential hypertension. Blood Pressure 1993; 2: 136-41.
14. Lindholm L, Hansson L, Dahlöf B, et al The Swedish Trial in Old Patients with Hypertension - 2(STOP-Hypertension-2): a progress report. Blood Pressure 1996; 5: 300-4.
15. The NORDIL Group. The Nordic Diltiazem Study (NORDIL). A prospective intervention trial of a calcium antagonist therapy in hypertension. Bload Pressure 1993; 2: 312-21.
16. Guidelines Sub-Committee. 1999 World Health Organization - International Society of Hypertension Guidelines for the Management of Hypertension. Blood Pressure 1999; 8 (Suppl 1): 9-43.